- Home
- MDWD vs QIPT Comparison
MDWD vs QIPT Comparison
Compare MDWD & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- QIPT
- Stock Information
- Founded
- MDWD 2000
- QIPT 1993
- Country
- MDWD Israel
- QIPT United States
- Employees
- MDWD N/A
- QIPT N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- QIPT
- Sector
- MDWD Health Care
- QIPT
- Exchange
- MDWD Nasdaq
- QIPT Nasdaq
- Market Cap
- MDWD 179.1M
- QIPT 118.5M
- IPO Year
- MDWD 2014
- QIPT N/A
- Fundamental
- Price
- MDWD $17.57
- QIPT $2.88
- Analyst Decision
- MDWD Strong Buy
- QIPT Strong Buy
- Analyst Count
- MDWD 1
- QIPT 3
- Target Price
- MDWD $28.00
- QIPT $7.67
- AVG Volume (30 Days)
- MDWD 54.1K
- QIPT 175.8K
- Earning Date
- MDWD 08-14-2024
- QIPT 08-14-2024
- Dividend Yield
- MDWD N/A
- QIPT N/A
- EPS Growth
- MDWD N/A
- QIPT N/A
- EPS
- MDWD N/A
- QIPT N/A
- Revenue
- MDWD $20,141,000.00
- QIPT $244,231,000.00
- Revenue This Year
- MDWD $30.16
- QIPT $25.19
- Revenue Next Year
- MDWD $18.44
- QIPT $6.04
- P/E Ratio
- MDWD N/A
- QIPT N/A
- Revenue Growth
- MDWD N/A
- QIPT 29.31
- 52 Week Low
- MDWD $7.45
- QIPT $2.60
- 52 Week High
- MDWD $24.00
- QIPT $5.70
- Technical
- Relative Strength Index (RSI)
- MDWD 47.71
- QIPT 48.38
- Support Level
- MDWD $17.50
- QIPT $2.68
- Resistance Level
- MDWD $17.90
- QIPT $2.96
- Average True Range (ATR)
- MDWD 0.89
- QIPT 0.10
- MACD
- MDWD 0.06
- QIPT 0.04
- Stochastic Oscillator
- MDWD 43.28
- QIPT 78.08
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.